GOVX
GeoVax Labs Inc
NASDAQ: GOVX · HEALTHCARE · BIOTECHNOLOGY
$1.05
-4.55% today
Updated 2026-04-29
Market cap
$3.21M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-22.40
Dividend yield
—
52W range
$1 – $35
Volume
0.1M
GeoVax Labs Inc (GOVX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-869.00%
ROE
-483.80%
ROA
-186.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $852905.00 | $-584166.00 | 100.00% | -76.95% | -68.49% |
| 2007 | $237004.00 | $-4.24M | 100.00% | -1,816.13% | -1,789.76% |
| 2008 | $2.91M | $-3.73M | 100.00% | -130.62% | -128.11% |
| 2009 | $3.67M | $-3.28M | 100.00% | -90.38% | -89.53% |
| 2010 | $5.19M | $-2.75M | 100.00% | -53.44% | -52.98% |
| 2011 | $4.90M | $-2.35M | 100.00% | -47.94% | -47.90% |
| 2012 | $2.66M | $-2.13M | 100.00% | -80.50% | -80.35% |
| 2013 | $2.42M | $-2.28M | -20.57% | -94.70% | -94.51% |
| 2014 | $882956.00 | $-2.73M | -105.33% | -310.05% | -309.59% |
| 2015 | $428081.00 | $-2.69M | -295.51% | -629.50% | -628.22% |
| 2016 | $828918.00 | $-3.27M | -137.76% | -394.90% | -394.70% |
| 2017 | $1.08M | $-2.17M | -87.61% | -202.22% | -201.82% |
| 2018 | $963000.00 | $-2.56M | -95.08% | -266.15% | -265.84% |
| 2019 | $1.18M | $-2.37M | 100.00% | -201.76% | -201.60% |
| 2020 | $1.82M | $-2.94M | 100.00% | -154.53% | -161.18% |
| 2021 | $385000.00 | $-18.53M | 100.00% | -4,869.09% | -4,813.37% |
| 2022 | $81000.00 | $-14.01M | 100.00% | -17,319.75% | -17,301.93% |
| 2023 | $0.00 | $-25.97M | — | — | — |
| 2024 | $3.95M | $-24.99M | 97.59% | -635.83% | -631.98% |
| 2025 | $2.49M | $-21.46M | 100.00% | -869.34% | -862.34% |